Our news

  • Telephone interventions for managing symptoms in adults with cancer. This is particularly important at the moment for people with cancer, who have been advised to stay at home due to COVID-19.People with cancer experience a variety of symptoms such as depression, anxiety, fatigue and pain caused by their disease and its treatment. These are often...
    June 3 2020
  • COVID-19 (coronavirus disease) - Cochrane Gynaecological, Neuro-oncology and Orphan CancersCoronavirus disease (COVID-19) is caused by a new strain of Coronavirus (SARS-CoV-2) discovered in 2019, and not previously identified in humans. Common symptoms include fever, cough, and shortness of breath. On March 11 2020, the World Health Organization (...
    April 14 2020
  • The aim of the register is to support rapid evidence synthesis by all systematic review producers, including Cochrane's work on Rapid Reviews in response to COVID-19. The register helps systematic reviewers prioritize topics, identify available evidence, and produce urgently needed reviews for front-line health professionals, public health...
    April 8 2020
  • COVID-19 pandemic: statement for CGNOC collaborators and colleaguesWe recognise that these are uncertain times and the impact of the COVID-19 pandemic will be felt by many of our collaborators and colleagues. We want to reassure all of you that your health, and your current priorities at work and home, are of the utmost importance to us.For those...
    March 30 2020
  • Green tea consumption and risk of developing cancer: can we make sense of it?Authors' conclusionsOverall, findings from experimental and nonexperimental epidemiological studies yielded inconsistent results, thus providing limited evidence for the beneficial effect of green tea consumption on the overall risk of cancer or on specific cancer sites....
    March 9 2020
  • Oral etoposide for treatment and/or maintenance treatment of recurrent epithelial ovarian cancer.Why it is important to do this review:Oral etoposide is a potential candidate for treatment and/or maintenance therapy of recurrent EOC, as it does not exhibit cross-resistance to platinum or paclitaxel which are used as the first-line chemotherapeutic...
    February 21 2020
  • Interventions to improve insulin resistance for the prevention of endometrial cancerBackgroundDescription of the conditionCancer of the womb (uterus) is the most common cancer affecting the female reproductive system in the developed world. Most womb cancers arise from abnormal growth of the womb lining (endometrium) and are termed endometrial...
    January 30 2020
  • Hormone replacement therapy for menopausal symptoms in women who have undergone surgical treatment for epithelial ovarian cancerPlain language summaryThe issue Epithelial ovarian cancer (EOC) develops from the surface layer of the ovary. It is the eighth most common cancer and the seventh most common cause of death from cancer worldwide in...
    January 30 2020
  • Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomasPlain language summaryAre there any differences in survival between people with low-grade glioma having early compared with delayed radiotherapy at the time of progression?The issue Low-grade gliomas (LGG) are brain tumours that predominantly affect young adults...
    January 30 2020
  • Get Social with Cochrane!!We aim to put Cochrane evidence at the heart of health decision-making all over the world. This not only means producing high-quality and relevant systematic reviews but making sure that our evidence is accessible and advocating for evidence. Join us on social media to learn more about the work we do, our community, and...
    January 6 2020

Pages

Subscribe to Our news